TYME TECHNOLOGIES, INC.
Healthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — |
| Operating income | −$25.5M | −$27.2M | −$25.8M | −$31.8M | −$19.4M | −$3.2M |
| Net income | −$23.6M | −$29.0M | −$22.0M | −$33.0M | −$19.0M | −$2.9M |
| Total assets | $88.0M | $110.3M | $29.5M | $17.5M | $31.0M | $10.7M |
| Total liabilities | $7.9M | $8.5M | $10.5M | $7.8M | $4.5M | $3.3M |
| Equity | $80.1M | $101.8M | $19.0M | $9.7M | $26.5M | $7.4M |
| EPS (diluted) | — | — | — | — | — | — |
| Shares out. | 172.2M | 172.2M | 123.3M | 112.0M | 101.2M | 89.3M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2022- Operating margin
- —
- Net margin
- —
- Return on equity
- −29.5%
- Return on assets
- −26.8%
- Return on capital (ROCE)
- −31.6%
- Liabilities / assets
- 9.0%
- Debt / equity
- 0.10×
- Book value / share
- $0.47
- Revenue growth (YoY)
- —
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2022- Altman Z″ (distress)
- 8.04safe
- Accruals / assets
- −2.7%clean
- Piotroski F-Score
- 2/7weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 severe● 1 warning● 3 good- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Negative operating cash flow
- Conservative leverage (liabilities < 50% of assets)
- Clean earnings (low accruals)
- Altman Z″ in the safe zone
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗Aug 9, 2017
- NT 10-Qmissed a reporting deadline ↗Feb 9, 2017
- NT 10-Qmissed a reporting deadline ↗Nov 16, 2015
- NT 10-Qmissed a reporting deadline ↗May 15, 2015
- NT 10-Qmissed a reporting deadline ↗Apr 15, 2015
- NT 10-Qmissed a reporting deadline ↗Jul 15, 2014
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Sokol Gerald HDirector | Sep 16, 2022 | D | 5,865 | — |
| Hoffman SteveDirector | Sep 16, 2022 | D | 20.0M | — |
| Porfido Frank L.Officer — Chief Financial Officer | Sep 16, 2022 | D | 10,000 | — |
| Michels Douglas ADirector | Sep 16, 2022 | D | 110,000 | — |
| Tyson TimothyDirector | Sep 16, 2022 | D | 5,865 | — |
| Galaini BarbaraOfficer — See remarks | Sep 16, 2022 | D | 258,300 | — |
| Biehl JamesOfficer — Chief Legal Officer | Sep 16, 2022 | D | 105,000 | — |
| Carberry DavidDirector | Sep 16, 2022 | D | 100,000 | — |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Material events
SEC Form 8-K · most recent- Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylawsSep 16, 2022
- Shareholder vote · Other material eventSep 15, 2022
- Other material eventSep 7, 2022
- Director / officer changeSep 6, 2022
- Other material eventSep 2, 2022
- Other material eventAug 24, 2022
- Entered a material agreement · Other material eventJul 5, 2022
- Delisting / listing-standard noticeJun 23, 2022
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 15-12GSep 30, 2022
- EFFECTSep 21, 2022
- EFFECTSep 21, 2022
- 4FORM 4 SUBMISSIONSep 16, 2022
- 4FORM 4 SUBMISSIONSep 16, 2022
- 4FORM 4 SUBMISSIONSep 16, 2022
- 4FORM 4 SUBMISSIONSep 16, 2022
- 4FORM 4 SUBMISSIONSep 16, 2022
- 4FORM 4 SUBMISSIONSep 16, 2022
- 4FORM 4 SUBMISSIONSep 16, 2022
- 4FORM 4 SUBMISSIONSep 16, 2022
- 4FORM 4 SUBMISSIONSep 16, 2022
- 4FORM 4 SUBMISSIONSep 16, 2022
- 4FORM 4 SUBMISSIONSep 16, 2022
- 4FORM 4 SUBMISSIONSep 16, 2022